PKBO — Peak Bio Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.52m
- $9.33m
- $0.37m
Annual balance sheet for Peak Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 0.35 | 0.205 | 0.655 | 0.382 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 0.634 | 0.459 | 3.23 | 2.37 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.536 | 0.381 | 4.06 | 0.153 |
Other Long Term Assets | ||||
Total Assets | 1.33 | 1.08 | 7.53 | 2.6 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 1.8 | 2.79 | 10.8 | 20.5 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Total Other Liabilities | ||||
Total Liabilities | 1.92 | 3.01 | 15.6 | 20.8 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | -0.593 | -1.94 | -8.09 | -18.2 |
Total Liabilities & Shareholders' Equity | 1.33 | 1.08 | 7.53 | 2.6 |
Total Common Shares Outstanding |